PSIOXUS THERAPEUTICS MOVES INTO NEW FACILITIES ON MILTON PARK TO ACCOMMODATE EXPANSION

New bespoke facilities to enable emerging biotech to further develop novel therapeutics that address cancer and other clinically unmet diseasesOxford, England: PsiOxus Therapeutics has opened a new state of the art laboratory at Milton Park as part of its expansion plans. The facility has been designed and equipped as a category two laboratory for the handling of live viruses, and will be key to the continued growth of PsiOxus. Dr John Beadle, Chief Executive Officer at PsiOxus says: "PsiOxus is developing novel viral based therapies and vaccines, with a particular focus upon the